• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial.

作者信息

Chaix Marie-A, Dore Annie, Mondésert Blandine, Mongeon François-Pierre, Roy Véronique, Desrosiers-Gagnon Charles, Guertin Marie-Claude, White Michel, Ibrahim Réda, O'Meara Eileen, Rouleau Jean-Lucien, Khairy Paul

机构信息

Adult Congenital Heart Center, Montreal Heart Institute, Department of Medicine, Université de Montréal, 5000 Belanger St.E., Montreal H1T 1C8, QC, Canada.

Montreal Health Innovations Coordinating Center (MHICC), Montreal Heart Institute, Université de Montréal, 5000 Belanger St. E., Montreal H1T 1C8, QC, Canada.

出版信息

Eur Heart J. 2024 Apr 21;45(16):1481-1483. doi: 10.1093/eurheartj/ehad890.

DOI:10.1093/eurheartj/ehad890
PMID:38445853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11032706/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d3/11032706/bd83572eb166/ehad890f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d3/11032706/bd83572eb166/ehad890f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d3/11032706/bd83572eb166/ehad890f1.jpg

相似文献

1
Angiotensin receptor-neprilysin inhibitor vs. placebo in congenital systemic right ventricular heart failure: the PARACYS-RV trial.血管紧张素受体-中性内肽酶抑制剂对比安慰剂治疗先天性系统性右心室心力衰竭：PARACYS-RV试验
Eur Heart J. 2024 Apr 21;45(16):1481-1483. doi: 10.1093/eurheartj/ehad890.
2
Subjective and Objective Impact of Angiotensin Receptor-Neprilysin Inhibitors on Systemic Right Ventricle Patients.血管紧张素受体-脑啡肽酶抑制剂对系统性右心室患者的主观和客观影响。
Heart Lung Circ. 2022 Jul;31(7):964-973. doi: 10.1016/j.hlc.2022.02.005. Epub 2022 Mar 9.
3
Durable ventricular assist device support for failing systemic morphologic right ventricle: early results.持久心室辅助装置支持功能衰竭的系统性形态学右心室：早期结果
Ann Thorac Surg. 2014 Dec;98(6):2122-9. doi: 10.1016/j.athoracsur.2014.06.054. Epub 2014 Oct 22.
4
Comparison of systemic right ventricular function in transposition of the great arteries after atrial switch and congenitally corrected transposition of the great arteries.大动脉调转术及先天性矫正型大动脉转位术后体循环右心室功能的比较
Int J Cardiovasc Imaging. 2017 Dec;33(12):1993-2001. doi: 10.1007/s10554-017-1201-4. Epub 2017 Jul 1.
5
Late outcome, therapy and systemic ventricular function in patients with a systemic right ventricle: data of the German National Register for Congenital Heart Defects.伴有体循环右心室的患者的远期结果、治疗和系统性心室功能：德国先天性心脏缺陷登记处的数据。
Cardiol Young. 2022 Aug;32(8):1235-1245. doi: 10.1017/S1047951121003954. Epub 2021 Oct 18.
6
Comparing Long-Term Sequelae of the Systemic Right Ventricle: An Overview of Single Versus Biventricular Arrangements.比较系统性右心室的长期后遗症：单心室与双心室排列的概述。
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2022;25:2-10. doi: 10.1053/j.pcsu.2022.05.002.
7
Mechanisms for heart failure in systemic right ventricle.系统性右心室心力衰竭的机制。
Heart Fail Rev. 2020 Jul;25(4):599-607. doi: 10.1007/s10741-019-09902-1.
8
Design of the rospective Comparison of ngiotensin eceptor-Neprilysin Inhibitor Versus Plcebo in Patients With ongenital stemic ight entricle Heart Failure (PARACYS-RV) Trial.先天性右心室心力衰竭患者中血管紧张素受体-中性肽链内切酶抑制剂与安慰剂的回顾性比较（PARACYS-RV）试验设计
CJC Open. 2023 Apr 26;5(7):537-544. doi: 10.1016/j.cjco.2023.04.004. eCollection 2023 Jul.
9
Predicting functional capacity in patients with a systemic right ventricle: subjective patient self-assessment is better than B-type natriuretic peptide levels and right ventricular systolic function.预测系统性右心室患者的功能能力：患者主观自我评估优于B型利钠肽水平和右心室收缩功能。
Congenit Heart Dis. 2013 Nov-Dec;8(6):550-5. doi: 10.1111/chd.12039. Epub 2013 Jan 28.
10
Long-term outcome following pregnancy in women with a systemic right ventricle: is the deterioration due to pregnancy or a consequence of time?右心室功能不全女性妊娠后的长期预后：病情恶化是妊娠所致还是时间推移的结果？
Congenit Heart Dis. 2013 Jul-Aug;8(4):302-7. doi: 10.1111/chd.12001. Epub 2012 Sep 12.

引用本文的文献

1
Impact of the angiotensin receptor-neprilysin inhibitor on chronic heart failure due to adult congenital heart disease: A systematic review and meta-analysis.血管紧张素受体脑啡肽酶抑制剂对成人先天性心脏病所致慢性心力衰竭的影响：一项系统评价和荟萃分析。
JHLT Open. 2025 Feb 18;8:100230. doi: 10.1016/j.jhlto.2025.100230. eCollection 2025 May.
2
Safety and Efficacy of Dapagliflozin in Patients With Systemic Right Ventricular Dysfunction: DAPA-SRV Trial.达格列净治疗系统性右心室功能障碍患者的安全性和有效性：DAPA-SRV试验
J Am Heart Assoc. 2025 Jun 3;14(11):e040302. doi: 10.1161/JAHA.124.040302. Epub 2025 May 29.
3
Hypoplastic left heart syndrome (HLHS) becomes of age: Assessing the young adult with HLHS including the neoaorta/aortic arch.

本文引用的文献

1
Design of the rospective Comparison of ngiotensin eceptor-Neprilysin Inhibitor Versus Plcebo in Patients With ongenital stemic ight entricle Heart Failure (PARACYS-RV) Trial.先天性右心室心力衰竭患者中血管紧张素受体-中性肽链内切酶抑制剂与安慰剂的回顾性比较（PARACYS-RV）试验设计
CJC Open. 2023 Apr 26;5(7):537-544. doi: 10.1016/j.cjco.2023.04.004. eCollection 2023 Jul.
2
Safety and Efficacy of Sacubitril/Valsartan in Patients With a Failing Systemic Right Ventricle: A Prospective Single-Center Study.沙库巴曲缬沙坦治疗右心室功能衰竭患者的安全性和有效性：一项前瞻性单中心研究
Circ Heart Fail. 2023 Feb;16(2):e009848. doi: 10.1161/CIRCHEARTFAILURE.122.009848. Epub 2022 Dec 2.
3
左心发育不全综合征（HLHS）步入成年期：评估患有HLHS的青年成人，包括新主动脉/主动脉弓。
Int J Cardiol Congenit Heart Dis. 2024 Nov 29;19:100555. doi: 10.1016/j.ijcchd.2024.100555. eCollection 2025 Mar.
4
Sacubitril/valsartan is associated with improvements in quality of life in adult congenital heart disease patients with systemic right ventricular failure.沙库巴曲缬沙坦可改善患有系统性右心室衰竭的成人先天性心脏病患者的生活质量。
Open Heart. 2025 Jan 30;12(1):e003009. doi: 10.1136/openhrt-2024-003009.
5
The Sub-Pulmonary Left Ventricle in Patients with Systemic Right Ventricle, the Paradoxical Neglected Chamber: A Cardiac Magnetic Resonance Feature Tracking Study.系统性右心室患者的肺下左心室：被忽视的矛盾腔室——一项心脏磁共振特征追踪研究
J Clin Med. 2024 Oct 10;13(20):6033. doi: 10.3390/jcm13206033.
Sacubitril/valsartan in the treatment of systemic right ventricular failure.
沙库巴曲缬沙坦治疗系统性右心衰竭。
Heart. 2021 Nov;107(21):1725-1730. doi: 10.1136/heartjnl-2020-318074. Epub 2021 Jan 15.
4
Medical Therapy for Systemic Right Ventricles: A Systematic Review (Part 1) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.系统性右心室医学治疗：2018 年 AHA/ACC 成人先天性心脏病管理指南的系统评价（第 1 部分）：美国心脏病学会/美国心脏协会实践指南工作组的报告。
J Am Coll Cardiol. 2019 Apr 2;73(12):1564-1578. doi: 10.1016/j.jacc.2018.08.1030. Epub 2018 Aug 16.
5
Systemic Right Ventricle in Adults With Congenital Heart Disease: Anatomic and Phenotypic Spectrum and Current Approach to Management.成人先天性心脏病的系统性右心室：解剖和表型谱及当前的治疗方法。
Circulation. 2018 Jan 30;137(5):508-518. doi: 10.1161/CIRCULATIONAHA.117.031544.
6
The natural and unnatural history of the Mustard procedure: long-term outcome up to 40 years. mustard 手术的自然史和非自然史：长达 40 年的长期结果。
Eur Heart J. 2014 Jul 1;35(25):1666-74. doi: 10.1093/eurheartj/ehu102. Epub 2014 Mar 18.
7
Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium.Mustard或Senning手术后长达30年的长期结局：比利时的一项全国性多中心研究。
Heart. 2004 Mar;90(3):307-13. doi: 10.1136/hrt.2002.007138.